Empagliflzin; significantly attenuates necrosis and prevent left ventricle systolic functions in doxorubicin induced cardiomyopathy via non-antioxidan pathways
31 August 2020 (11:14 - 11:22)
Organised by:
Slides
About the speaker
Dr Ersin Arslan Research and Training Hospital, Gaziantep (Turkiye)
4 More presentations in this session
Professor C. Perrino (Naples, IT)
Doctor J. Gambardella (Napoly, IT)
Doctor G. Mingrone (Candiolo, IT)
Doctor T. Kulikova (Moscow, RU)
Access the full session
The Event
ESC Congress 2020
31 August 2020
11:14 CET
/f/125658/640x360/fe5123d923/ett-s3-ep15.png)
